Triple-negative breast cancer, which accounts for about 10%–15% of all breast cancers, is an aggressive type of cancer that has limited treatment options and tends to have a worse prognosis for patients. The new studypublishedinMolecular Cancer, reveals that aproteincalled NAC1 plays a role ...
SCCA is a clinical trials site for some of these therapies.Spare the radiation treatment but not the cancer: Radiation oncologists at SCCA arcancernews.comBreast Cancer Treatment New Research Suggests Sometimes Less Is More
The scientists are now testing the efficacy of their combination therapy in pre-clinical animal models with a view to future testing in clinical trials for breast cancer treatment. Read the full storyhere. Read the publication in Molecular Cell titled:Control of Glucocorticoid Receptor Levels by PTE...
However, when there was an atypical ductal hyperplasia (ADH), or abnormal cells, the study found pathologists were only able to match 48 percent correctly – less than half of cases. What this implies is in cases that may not need any further treatment, pathologists were reading them as carc...
A new study shows that a novel imaging-based method for defining appropriateness of breast cancer treatment is as accurate as the current standard-of-care and could reduce the need for invasive tissue sampling. The results suggest that ...
A new study by University of Kentucky researchers provides insight into developing new treatment strategies for basal-like breast cancer, commonly known as triple-negative breast cancer. This cancer is associated with early metastasis and resistance to chemotherapy and occurs at women at a younger age...
Patients are selected for treatment with Lynparza based on an FDA-approved genetic test. "This class of drugs has been used to treat advanced, BRCA-mutated ovarian cancer and has now shown efficacy in treating certain types of BRCA-mutated breast cancer," said Richard Pazdur, director of the...
commentary new treatments for breast cancer: breakthroughs for patient care or just steps in the right direction? A new study by University of Kentucky researchers provides insight into developing new treatment strategies for basal-like breast cancer, commonly known as... A Goldhirsch,AS Coates,M ...
When cancer is detected early, patients live longer, require less extensive treatment, and in general fare better than patients with more advanced disease... DAC Jotwani,JR Gralow - 《Molecular Diagnosis & Therapy》 被引量: 9发表: 2009年 Endoxifen shows promise in breast cancer In a phase I...
Canada's current national screening guidelines for breast cancer are less appropriate for women of certain race and ethnicity groups since they are diagnosed at younger ages with more advanced stages of the disease. The new findings from a University of